SOUTHLAKE, Texas--(BUSINESS WIRE)--OncoNano Medicine, Inc. today announced a clinical trial supply agreement with Regeneron for the use of Libtayo ® (cemiplimab), a PD-1 inhibitor, in the combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback